Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.

Name: Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.
Author: Sarkar, Reith R

Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia. — المؤلف: Sarkar, Reith R — Journal of the National Cancer Institute 20200708

المؤلف: Sarkar, Reith R
النشر: Journal of the National Cancer Institute 20200708
الوصف: 719-726 p.
الموضوعات: B-Lymphocytes؛ Child؛ Cost-Benefit Analysis؛ Disease-Free Survival؛ Female؛ Humans؛ Immunotherapy, Adoptive؛ Male